Impact of diclofenac use on the incidence and severity of ischemic colitis: A systematic rewiew
DOI:
https://doi.org/10.56294/piii2024335Keywords:
Colitis, Ischemia, Diclofenac, Colon, Nonsteroidal anti-inflammatory agentsAbstract
Introduction: ischemic colitis is an inflammation of the colon caused by reduced blood flow, and represents the most common form of intestinal ischemia. Symptoms can range from mild discomfort to severe complications such as intestinal perforation. Diclofenac, a commonly used non-steroidal anti-inflammatory drug (NSAID), is associated with gastrointestinal complications, and recent studies suggest a possible link between its use and ischemic colitis.
Objective: to evaluate the impact of diclofenac use on the incidence and severity of ischemic colitis through a systematic review of the scientific literature.
Methods: a search was carried out in PubMed and SciELO databases using key terms such as “Colitis”, “Ischemia”, “Diclofenac”, “Colon” and “Anti-Inflammatory Agents, Non-Steroidal”. Observational studies, clinical trials, and case reports addressing the relationship between diclofenac and ischemic colitis were included. Data were analyzed to determine the incidence and severity of colitis in patients treated with diclofenac.
Results: The studies reviewed indicated a significant relationship between the use of diclofenac and the occurrence of ischemic colitis. Cases of diclofenac-induced acute colitis were described. Other studies identified a correlation between NSAID use and recent diagnosis of ischemic colitis, possibly related to prostaglandin inhibition, which affects intestinal perfusion.
Conclusion: diclofenac use may increase the risk of ischemic colitis. It is crucial that physicians evaluate therapeutic alternatives with lower risk and monitor patients with predisposing factors. Further research is needed to confirm a causal relationship and develop preventive strategies
References
1. Washington C, Carmichael JC. Management of Ischemic Colitis. Clin Colon Rectal Surg. diciembre de 2012;25(4):228- 35.
2. Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ, American College of Gastroenterology. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). Am J Gastroenterol. enero de 2015;110(1):18-44; quiz 45.
3. Theodoropoulou Α, Κoutroubakis IE. Ischemic colitis: Clinical practice in diagnosis and treatment. World J Gastroenterol. 28 de diciembre de 2008;14(48):7302-8.
4. Pérez Ruiz AA, López Mantecón AM, Grau León I. Antiinflamatorios no esteroideos (AINES).: Consideraciones para su uso estomatológico. Revista Cubana de Estomatología. agosto de 2002;39(2):119- 38.
5. Bielsa Martín S., Porcel Pérez J. M., Madroñero Vuelta A. B., Planella Rubinat, M. J.. Colitis aguda por diclofenaco. Rev. esp. enferm. dig. [Internet]. 2006 Mar [citado 2024 Abr 05] ; 98( 3 ): 226-227. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082006000300015&lng=es.
6. Gleeson MH, Davis AJ. Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther. 2003 Mar 15;17(6):817-25.doi:10.1046/j.1365-2036.2003.01519.x. PMID: 12641504.
7. Sierra Gabarda O, Espinosa Pérez M, Casas Deza D, Lamuela Calvo LJ, Llorente Barrio M, Monzón Báez RM, Sierra Moros E, Alcedo González J. NSAID-induced ischemic colitis. Rev Esp Enferm Dig. 2022 May;114(5):307. doi: 10.17235/reed.2022.8605/2022. PMID:35067065.
8. Vieth M. NSAR-Kolopathie [NSAID- colonopathy]. Pathologe. 2006 Feb;27(1):65-72. German. doi: 10.1007/s00292-005-0810-1. PMID:16369762.
9. Gleeson MH, Davis AJ. Non-steroidal anti- inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther. 2003 Mar 15;17(6):817-25.doi:10.1046/j.1365-2036.2003.01519.x. PMID: 12641504.
10. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993 Jun;104(6):1832-47. doi: 10.1016/0016- 5085(93)90667-2. PMID: 8500743.
11. Byrne MF, McGuinness J, Smyth CM, Manning DS, Sheehan KM, Bohra SG, Patchett SE, Murray FE. Nonsteroidal anti- inflammatory drug-induced diaphragms and ulceration in the colon. Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1265-9. doi: 10.1097/00042737-200211000-00017. PMID: 12439124.
13. Katsinelos P, Christodoulou K, Pilpilidis I, Xiarchos P, Papagiannis A, Dimiropoulos S, Amperiadis P, Vasiliadis T, Tarpagos A, Katsos I, Eugenidis N. Colopathy associated with the systemic use of nonsteroidal antiinflammatory medications. An underestimated entity. Hepatogastroenterology.2002Mar-Apr;49(44):345-8. PMID: 11995447.
14. Villota-Arcos C, Roco-Videla A, Pino-Astorga C, Mendoza-Puga D, Bittner M, Corbeaux-Ascui T, et al. Effect of intermittent fasting on C-reactive protein and calprotectin levels in a Patient with Ulcerative Colitis. A case report. Salud, Ciencia y Tecnología. 2024;4:1021. https://doi.org/10.56294/saludcyt20241021
15. Valido Valdes D, Benítez Falero Y, Junco Sena B, Sánchez Rodríguez Y, Gallardo Romero E. Risk factors for colorectal cancer, a present and a future. AG Salud. 2024; 2:49. https://doi.org/10.62486/agsalud202449
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Luciano Josué Loyola Bolognesi, Marcelo Adrián Estrin (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
